BMS Launches Pilot Program With WHO In Five African Countries
This article was originally published in PharmAsia News
Executive Summary
Bristol-Myers Squibb is scaling up its community-based tuberculosis interventions to support HIV-positive populations in Africa. The U.S. drug maker's charity wing, Bristol-Myers Squibb Foundation signed a collaboration agreement with the World Health Organization and committed $1.2 million to help develop a global guidance involving national TB programs to fight tuberculosis
You may also be interested in...
Seeking Broad Intervention In India, Eli Lilly Goes To Roots To Check Non-communicable Diseases
MUMBAI - Following the Indian government's heightened concerns over a sharply increased prevalence rate of non-communicable diseases such as diabetes and cancer, Eli Lilly & Co. has allocated $8-9 million to analyze the disease burden in India and devise intervention strategies based on the data
Technology Transfers To Least-Developed Countries Often Not An Option - IFPMA Report
HONG KONG - The transfer of technology developed by high-end research-based pharmaceutical companies to operations in developing countries is increasingly common, but rarely simple
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).